![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Schering-plough Europe Brussels Be, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Loratadine, Micronised, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-218 - Rev 00
This Chemical Type CEP, issued on December 19, 2013, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2124 associated with this CEP further emphasizes